IPAC2011 - List of Authors (Lazarev, V.)

Paper	Title	Page
THPS066	Technical Overview of the SIEMENS Particle Therapy Accelerator	3577
	V. Lazarev, O. Chubarov, S. Emhofer, G. Franzini, S. Göller, B. Nagorny, A. Robin, H. Rohdjess, R. Rottenbach, A.C. Sauer, R. Schedler, T. Sieber, B. Steiner, J. Tacke, D.B. Thorn, T. Uhl, P. Urschütz, O. Wilhelmi Siemens Med, Erlangen, Germany M. Budde, J.S. Gretlund, H.B. Jeppesen, C.V. Nielsen, C.G. Pedersen, Ka.T. Therkildsen, S.V. Weber Siemens DK, Jyllinge, Denmark
	Siemens has developed an accelerator system for particle therapy. It consists of an injector (7 MeV/u protons and light ions) and a compact synchrotron able to accelerate proton beams up to 250 MeV and carbon ions up to 430 MeV/u. These beams are extracted slowly from the synchrotron and delivered to a number of beam ports. The first accelerator system has been built and commissioned up to the first two beam outlets. An overview of the achieved performance of the system is presented. *Particle therapy is a work in progress and requires country-specific regulatory approval prior to clinical use.

Paper

Title

Page

Technical Overview of the SIEMENS Particle Therapy Accelerator

3577

V. Lazarev, O. Chubarov, S. Emhofer, G. Franzini, S. Göller, B. Nagorny, A. Robin, H. Rohdjess, R. Rottenbach, A.C. Sauer, R. Schedler, T. Sieber, B. Steiner, J. Tacke, D.B. Thorn, T. Uhl, P. Urschütz, O. Wilhelmi
Siemens Med, Erlangen, Germany
M. Budde, J.S. Gretlund, H.B. Jeppesen, C.V. Nielsen, C.G. Pedersen, Ka.T. Therkildsen, S.V. Weber
Siemens DK, Jyllinge, Denmark

Siemens has developed an accelerator system for particle therapy. It consists of an injector (7 MeV/u protons and light ions) and a compact synchrotron able to accelerate proton beams up to 250 MeV and carbon ions up to 430 MeV/u. These beams are extracted slowly from the synchrotron and delivered to a number of beam ports. The first accelerator system has been built and commissioned up to the first two beam outlets. An overview of the achieved performance of the system is presented.
*Particle therapy is a work in progress and requires country-specific regulatory approval prior to clinical use.